Conference Coverage

Do not miss cannabis use in gastroparesis patients


 

REPORTING FROM DIGESTIVE DISEASES: NEW ADVANCES

PHILADELPHIA – When evaluating potential causes of gastroparesis, cannabis use is a “do not miss” diagnosis that is easy to overlook and likely on the rise, according to Anthony J. Lembo, MD.

“This is not an infrequent problem, and I’ve even missed it a couple of times,” said Dr. Lembo, director of the GI Motility Laboratory at Beth Israel Deaconess Medical Center, Boston.

The rate of U.S. emergency department visits for vomiting with cannabis use disorder rose from 2.3 to 13.3 per 100,000 visits from 2006 to 2013, according to an analysis recently published by Dr. Lembo and colleagues (J Clin Gastroenterol. 2017 Oct 31. doi: 10.1097/MCG.0000000000000944).

The study showed that men between 20 and 29 years were the most common group presenting for vomiting with cannabis use disorder.

Pages

Recommended Reading

Heart attacks soar in young IBD patients
MDedge Internal Medicine
Buy the IBD, get the comorbidity for free
MDedge Internal Medicine
Xeljanz: FDA panel recommends ulcerative colitis indication
MDedge Internal Medicine
Nonendoscopic nonmalignant polyp surgery increasing despite greater risk
MDedge Internal Medicine
FDA issues warning to all duodenoscope manufacturers
MDedge Internal Medicine
New study establishes IBD severity index
MDedge Internal Medicine
Gut bacteria could drive autoimmune response in genetically predisposed
MDedge Internal Medicine
Colorectal cancer risk stratification enhanced by combining family history and genetic risk scores
MDedge Internal Medicine
MDedge Daily News: Why the barber’s chair can help hypertension
MDedge Internal Medicine
Bile spillage during lap cholecystectomy comes with a price
MDedge Internal Medicine